|
""Born to be Bad"": Is Abnormal Cell Mobility Already Present At Initiation?
|
1R21CA185016-01
|
$214,618
|
SHIBATA, DARRYL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
|
1R21CA184920-01
|
$230,659
|
THOMPSON, PATRICIA
|
UNIVERSITY OF ARIZONA
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
1R01CA190092-01
|
$555,711
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
(PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention
|
5R01CA179949-02
|
$460,691
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon Cancer
|
5R01CA180087-02
|
$417,523
|
LI, YAN CHUN
|
UNIVERSITY OF CHICAGO
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
1R01CA184820-01
|
$399,474
|
DUBOIS, RAYMOND
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
|
5R01CA179977-02
|
$715,557
|
KERR, JACQUELINE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip
|
5R01CA180083-02
|
$506,129
|
QIN, LIDONG
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
|
1R01CA184926-01
|
$799,422
|
JAFFEE, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQB-3) Roles of skeletal muscle mass in chemotherapy-associated cachexia
|
1R21CA190028-01
|
$203,580
|
BONETTO, ANDREA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
1R01CA184572-01
|
$329,925
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
(PQB-4) Single cell analysis strategy for monitoring drug responses of tumors
|
1R01CA190122-01
|
$591,830
|
TIAN, QIANG
|
INSTITUTE FOR SYSTEMS BIOLOGY
|
|
(PQB4)SIRT6 Modulates Cancer Metabolism During Aging
|
1R21CA185416-01
|
$176,349
|
MOSTOSLAVSKY, RAUL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
|
7R01CA179991-02
|
$354,825
|
IACOBUZIO-DONAHUE, CHRISTINE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
5R01CA180149-02
|
$557,736
|
AGUS, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQC-1) Driver Events In IBD-Associated Neoplastic Progression
|
1R01CA190040-01
|
$613,138
|
MELTZER, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field Cancerization
|
1R01CA185207-01
|
$668,299
|
RICHARDS-KORTUM, REBECCA
|
RICE UNIVERSITY
|
|
(PQC2)High-content Pathology with Confocal Microscope Arrays
|
5R01CA180152-02
|
$623,480
|
CONTAG, CHRISTOPHER
|
STANFORD UNIVERSITY
|
|
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
|
1R21CA185536-01
|
$208,800
|
BHATTACHARYA, PRATIP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
1R01CA185357-01
|
$459,341
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQD6) Muscle stem cells and cancer cachexia
|
5R01CA180057-02
|
$357,894
|
GUTTRIDGE, DENIS
|
OHIO STATE UNIVERSITY
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192973-01
|
$191,836
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplas
|
1U01CA181770-01
|
$561,786
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in toba
|
5R01CA134700-06
|
$268,252
|
TURESKY, ROBERT
|
UNIVERSITY OF MINNESOTA
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192976-01
|
$144,556
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
402 -- TITLE: PHASE I TRIAL OF BERBERINE IN SUBJECTS WITH ULCERATIVE COLITIS. CON
|
261201200035I
|
$2,073,589
|
UNKNOWN, UNKNOWN
|
NORTHWESTERN UNIVERSITY
|
|
4D Robust Optimization in Intensity-Modulated Proton Therapy
|
5K25CA168984-03
|
$99,908
|
LIU, WEI
|
MAYO CLINIC ARIZONA
|
|
A 3-D In Vitro Platform of Tumor Metastasis (PQ24)
|
7R01CA170879-03
|
$332,671
|
GEORGE, STEVEN
|
WASHINGTON UNIVERSITY
|
|
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation
|
7K01CA181292-02
|
$119,534
|
CASTILLO, RICHARD
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
A Chemopreventive Strategy Based on Edible MicroRNAs Produced in Plants
|
1R03CA181895-01A1
|
$73,250
|
VANCE, VICKI
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
A Cohort Study of Sessile Serrated Polyps and Subsequent Colorectal Neoplasia
|
5R01CA168338-02
|
$647,425
|
NEWCOMB, POLLY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)
|
5R01CA170495-03
|
$341,162
|
CAGAN, ROSS
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-03
|
$1,262,499
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans
|
5U01CA158428-03
|
$284,046
|
BUCKHAULTS, PHILLIP
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
A Genetic Screen for HCC Genes
|
5R01CA132962-05
|
$293,831
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA
|
|
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
|
1R21CA176561-01A1
|
$159,818
|
COLLISSON, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
|
5K08CA137153-05
|
$163,080
|
COLLISSON, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A molecular mechanism whereby metformin protects against liver cancer
|
1R21CA185021-01
|
$189,664
|
XIAO, HUA
|
MICHIGAN STATE UNIVERSITY
|
|
A mouse model for human gastrointestinal stromal tumor
|
5R01CA102774-10
|
$363,278
|
BESMER, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy
|
5K24CA139570-05
|
$140,411
|
NELSON, DAVID
|
UNIVERSITY OF FLORIDA
|
|
A New Strategy for Cancer Detection using Raman Spectroscopy with Nanoparticles
|
1K22CA160834-01A1
|
$193,860
|
ZAVALETA, CRISTINA
|
STANFORD UNIVERSITY
|
|
A Novel Agent That Reduces Radiation Side Effects in Head and Neck Cancer Patient
|
N43CA130014-004
|
$1,499,978
|
ZARLING, DAVID
|
COLBY PHARMACEUTICAL COMPANY
|
|
A Novel Agent with Dual Functions to Treat Head and Neck Cancer
|
1R21CA176032-01A1
|
$206,190
|
TOBACK, FREDERICK
|
UNIVERSITY OF CHICAGO
|
|
A novel compound for colorectal cancer prevention
|
1R03CA181845-01A1
|
$74,521
|
SHARMA, ARUN
|
PENNSYLVANIA STATE UNIVERSITY
|
|
A Novel genomics-based approach to differentiate HPV-positive and -negative HNC
|
1R21CA182661-01A1
|
$203,580
|
SABA, NABIL
|
EMORY UNIVERSITY
|
|
A Novel Mechanism for LEF1 Promoter Regulation in Colon Cancer
|
1F32CA186620-01
|
$51,530
|
DENMON, ANDRIA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
A novel mediator of obesity associated hepatocellular carcinoma (HCC)
|
1R21CA183954-01
|
$199,013
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
A novel regimen to target both pancreatic cancer K-ras and antiapoptotic proteins
|
1R03CA182552-01
|
$84,900
|
LI, FENGZHI
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A Pooled Analysis of 25-hydroxyvitamin D and Colorectal Cancer Survival
|
1R03CA183016-01A1
|
$93,395
|
FEDIRKO, VERONIKA
|
EMORY UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|